Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...
Statin users had a significantly lower 10-year cumulative incidence of hepatocellular carcinoma and hepatic decompensation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback